Table I.
Clinical and pathological features of the 21 patients with bladder cancer.
| Characteristics | Value |
|---|---|
| Median age (range), years | 74 (50–89) |
| Gender (male:female), n | 19:2 |
| Pathological T stage, n (%) | |
| pTa | 11 (52.4) |
| pT1 | 6 (28.6) |
| pT2 | 4 (19.0) |
| Tumor grade, n (%) | |
| I | 2 (9.5) |
| II | 11 (52.4) |
| III | 8 (38.1) |
| No. of tumors (%) | |
| 1 | 12 (57.1) |
| >1 | 9 (42.9) |
| Recurrence status, n (%) | |
| Primary | 12 (57.1) |
| Recurrent | 9 (42.9) |
| CIS presence, n (%) | |
| None | 16 (76.2) |
| Presence | 5 (23.8) |
| Recurrent after TUR, n (%) | |
| None | 12 (57.1) |
| Recurrence | 9 (42.9) |
| Treatment after TUR, n (%) | |
| None | 11 (52.4) |
| BCG | 5 (23.8) |
| 2nd TUR | 1 (4.8) |
| Total cystectomy | 4 (19.0) |
TUR, transurethral resection; BCG, bacillus calmette-guérin; CIS, carcinoma in situ; T stage, tumor stage.